• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型去氢枞酸 1H-苯并[d]咪唑衍生物的合成及其作为 PI3Kα 抑制剂的抗癌活性评价。

Synthesis and anticancer evaluation of novel 1H-benzo[d]imidazole derivatives of dehydroabietic acid as PI3Kα inhibitors.

机构信息

Jiangsu Provincial Key Lab for the Chemistry and Utilization of Agro-forest Biomass, Jiangsu Key Lab of Biomass-based Green Fuels and Chemicals, Co-Inovation Center for Efficient Processing and Utilization of Forest Products, College of Chemical Engineering, Nanjing Forestry University, Nanjing 210037, PR China.

Jiangsu Provincial Key Lab for the Chemistry and Utilization of Agro-forest Biomass, Jiangsu Key Lab of Biomass-based Green Fuels and Chemicals, Co-Inovation Center for Efficient Processing and Utilization of Forest Products, College of Chemical Engineering, Nanjing Forestry University, Nanjing 210037, PR China.

出版信息

Bioorg Chem. 2020 Jul;100:103845. doi: 10.1016/j.bioorg.2020.103845. Epub 2020 Apr 10.

DOI:10.1016/j.bioorg.2020.103845
PMID:32344183
Abstract

Phosphatidylinositol 3-kinase (PI3K) is one of the most attractive therapeutic targets for cancer treatment. In this study, a series of new 2-arylthio- and 2-arylamino-1H-benzo[d]imidazole derivatives of dehydroabietic acid were designed, synthesized and characterized by H NMR, C NMR, IR and MS spectra analyses. In the in vitro anticancer assay, some title compounds showed significant inhibitory activities against four cancer cell lines (HCT-116, MCF-7, HeLa and HepG2). Among them, compound 9g exhibited the most potent activity with IC values of 0.18 ± 0.03, 0.43 ± 0.05, 0.71 ± 0.08 and 0.63 ± 0.09 μM against four cancer cell lines, and considerably lower cytotoxicity to human gastric mucosal cell line Ges-1 (IC: 21.95 ± 0.73 μM). Besides, compound 9g displayed a certain selective activity to PI3Kα (IC = 0.012 ± 0.002 μM) over PI3Kβ, γ and δ, and meanwhile, it can remarkably decrease the expression level of p-Akt (Ser473). In addition, compound 9g could increase intracellular reactive oxygen species level, decrease mitochondrial membrane potential, upregulate Bax and cleaved caspase-3/9 levels, downregulate Bcl-2 level and thus induce the apoptosis of HCT-116 cells in a dose-dependent manner. The results suggested that compound 9g could be considered as a promising PI3Kα inhibitor.

摘要

磷酸肌醇 3-激酶(PI3K)是癌症治疗中最有吸引力的治疗靶点之一。在这项研究中,设计、合成并通过 H NMR、C NMR、IR 和 MS 谱分析对一系列新的去氢枞酸 2-芳基硫代-和 2-芳基氨基-1H-苯并[d]咪唑衍生物进行了表征。在体外抗癌测定中,一些标题化合物对四种癌细胞系(HCT-116、MCF-7、HeLa 和 HepG2)表现出显著的抑制活性。其中,化合物 9g 表现出最强的活性,对四种癌细胞系的 IC 值分别为 0.18±0.03、0.43±0.05、0.71±0.08 和 0.63±0.09μM,对人胃黏膜细胞系 Ges-1 的细胞毒性也明显较低(IC:21.95±0.73μM)。此外,化合物 9g 对 PI3Kα(IC=0.012±0.002μM)表现出一定的选择性,而对 PI3Kβ、γ和δ的选择性较低,同时,它可以显著降低 p-Akt(Ser473)的表达水平。此外,化合物 9g 可以增加细胞内活性氧水平,降低线粒体膜电位,上调 Bax 和 cleaved caspase-3/9 水平,下调 Bcl-2 水平,从而以剂量依赖的方式诱导 HCT-116 细胞凋亡。结果表明,化合物 9g 可被认为是一种有前途的 PI3Kα 抑制剂。

相似文献

1
Synthesis and anticancer evaluation of novel 1H-benzo[d]imidazole derivatives of dehydroabietic acid as PI3Kα inhibitors.新型去氢枞酸 1H-苯并[d]咪唑衍生物的合成及其作为 PI3Kα 抑制剂的抗癌活性评价。
Bioorg Chem. 2020 Jul;100:103845. doi: 10.1016/j.bioorg.2020.103845. Epub 2020 Apr 10.
2
Development of novel chromeno[4,3-c]pyrazol-4(2H)-one derivates containing piperazine as inhibitors of PI3Kα.新型含哌嗪的色烯并[4,3-c]吡唑-4(2H)-酮衍生物的开发作为 PI3Kα 的抑制剂。
Bioorg Chem. 2019 Nov;92:103238. doi: 10.1016/j.bioorg.2019.103238. Epub 2019 Aug 30.
3
Development of novel chromeno[4,3-c]pyrazol-4(2H)-one derivates bearing sulfonylpiperazine as antitumor inhibitors targeting PI3Kα.新型含磺酰基哌嗪的色烯并[4,3-c]吡唑-4(2H)-酮衍生物的开发作为针对 PI3Kα 的抗肿瘤抑制剂。
Eur J Med Chem. 2019 Nov 15;182:111630. doi: 10.1016/j.ejmech.2019.111630. Epub 2019 Aug 18.
4
Design, synthesis and evaluation of some 1,6-disubstituted-1H-benzo[d]imidazoles derivatives targeted PI3K as anticancer agents.设计、合成与评价一些作为抗癌药物的靶向 PI3K 的 1,6-二取代-1H-苯并[d]咪唑衍生物。
Bioorg Chem. 2019 Dec;93:103283. doi: 10.1016/j.bioorg.2019.103283. Epub 2019 Sep 14.
5
Design, Synthesis, Biological Evaluation, and Molecular Modeling of 2-Difluoromethylbenzimidazole Derivatives as Potential PI3Kα Inhibitors.2-二氟甲基苯并咪唑衍生物的设计、合成、生物评价及作为潜在的 PI3Kα 抑制剂的分子建模。
Molecules. 2022 Jan 8;27(2):387. doi: 10.3390/molecules27020387.
6
Ligand-Based Drug Design: Synthesis and Biological Evaluation of Substituted Benzoin Derivatives as Potential Antitumor Agents.基于配体的药物设计:作为潜在抗肿瘤剂的取代苯偶姻衍生物的合成与生物学评价
Med Chem. 2019;15(4):417-429. doi: 10.2174/1573406414666180912111846.
7
Design, synthesis and biological evaluation of novel chromeno[4,3-c]pyrazol-4(2H)-one derivates containing sulfonamido as potential PI3Kα inhibitors.新型含磺酰胺基的色烯并[4,3-c]吡唑-4(2H)-酮衍生物的设计、合成及作为潜在 PI3Kα 抑制剂的生物评价。
Bioorg Med Chem. 2019 Jun 1;27(11):2261-2267. doi: 10.1016/j.bmc.2019.04.021. Epub 2019 Apr 15.
8
Docking Studies and Antiproliferative Activities of 6-(3-aryl-2-propenoyl)-2(3H)- benzoxazolone Derivatives as Novel Inhibitors of Phosphatidylinositol 3-Kinase (PI3Kα).作为新型磷脂酰肌醇 3-激酶(PI3Kα)抑制剂的 6-(3-芳基-2-丙烯酰基)-2(3H)-苯并恶唑酮衍生物的对接研究和抗增殖活性。
Anticancer Agents Med Chem. 2021;21(6):716-724. doi: 10.2174/1871520620666200807221731.
9
Synthesis and biological evaluation of novel -(piperazin-1-yl)alkyl-1-dibenzo[,]carbazole derivatives of dehydroabietic acid as potential MEK inhibitors.新型去氢枞酸-(哌嗪-1-基)烷基-1-二苯并[,]咔唑衍生物的合成及作为潜在 MEK 抑制剂的生物评价。
J Enzyme Inhib Med Chem. 2019 Dec;34(1):1544-1561. doi: 10.1080/14756366.2019.1655407.
10
Synthesis and antitumor evaluation of (aryl)methyl-amine derivatives of dehydroabietic acid-based B ring-fused-thiazole as potential PI3K/AKT/mTOR signaling pathway inhibitors.基于去氢枞酸 B 环稠合噻唑的(芳基)甲基胺衍生物的合成及抗肿瘤活性评价作为潜在的 PI3K/AKT/mTOR 信号通路抑制剂。
Mol Divers. 2021 May;25(2):967-979. doi: 10.1007/s11030-020-10081-7. Epub 2020 Apr 15.

引用本文的文献

1
New imidazole-2-thiones linked to acenaphythylenone as dual DNA intercalators and topoisomerase II inhibitors: structural optimization, docking, and apoptosis studies.新型咪唑-2-硫酮连接苊并菲醌作为双重 DNA 嵌入剂和拓扑异构酶 II 抑制剂:结构优化、对接和细胞凋亡研究。
J Enzyme Inhib Med Chem. 2024 Dec;39(1):2311818. doi: 10.1080/14756366.2024.2311818. Epub 2024 Mar 15.
2
Design, synthesis, and antiproliferative evaluation of novel dehydroabietic acid-1,2,3-triazole-oxazolidinone hybrids.新型脱氢枞酸-1,2,3-三唑-恶唑烷酮杂化物的设计、合成及抗增殖活性评价
RSC Med Chem. 2024 Jan 11;15(2):561-571. doi: 10.1039/d3md00550j. eCollection 2024 Feb 21.
3
Synthesis and Bioactivity Evaluation of Nepetaefolin F and Its Analogues.
尼泊尔酮F及其类似物的合成与生物活性评价
ACS Omega. 2023 Apr 12;8(16):14830-14840. doi: 10.1021/acsomega.3c01319. eCollection 2023 Apr 25.
4
Imidazoles as Potential Anticancer Agents: An Update on Recent Studies.咪唑类化合物作为潜在的抗癌剂:近期研究进展综述。
Molecules. 2021 Jul 11;26(14):4213. doi: 10.3390/molecules26144213.
5
5-Aryl-1-Arylideneamino-1-Imidazole-2(3)-Thiones: Synthesis and In Vitro Anticancer Evaluation.5-芳基-1-芳亚氨基-1-咪唑-2(3)-硫酮:合成与体外抗癌活性评价。
Molecules. 2021 Mar 18;26(6):1706. doi: 10.3390/molecules26061706.